Elicio Therapeutics Inc (ELTX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -187.81 | -211.134 | -270.481 | -75.87 | -51.984 | -88.058 |
Return on Equity (%) | -264.449 | -25020.308 | 146.938 | 1220.599 | -61.953 | -127.645 |
Return on Invested Capital (%) | -159.542 | 1249.304 | 95.894 | 742.132 | -64.069 | -140.562 |
Operating Margin (%) | -497.022 | -2734.23 | -2474.34 | -186.232 | -1686.528 | N/A |
Net Profit Margin (%) | -620.625 | -2734.23 | -2781.493 | -192.756 | -1686.528 | N/A |
Book Value Per Share | 2.039 | -2.002 | -5.905 | 2.721 | 1.454 | 1.353 |
Earnings Per Share | -2.696 | -4.378 | -5.23 | -1.822 | -1.289 | -4.186 |
Cash Per Share | 2.751 | 0.6 | 2.259 | 2.963 | 1.677 | 1.534 |
Working Capital Per Share | 1.976 | -2.204 | -4.254 | 2.669 | 1.496 | 0.783 |
Operating Profit Per Share | 0.394 | 0.097 | 0.117 | 0.934 | 0.076 | N/A |
EBIT Per Share | -2.159 | -4.378 | -5.23 | -1.822 | -1.289 | -4.186 |
EBITDA Per Share | -2.159 | -4.378 | -5.23 | -1.822 | -1.289 | -4.186 |
Free Cash Flow Per Share | -2.696 | -4.358 | -5.234 | -1.812 | -1.295 | -4.224 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 9,28M | 9,29M | 15,32M | 29,96M | 30,11M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | 30,11M | N/A | 8,37M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 83,52M |
Ratio cours/bénéfice | -2,37 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 6,48 |
Ratio prix/valeur comptable | 7,34 |
Rendement de dividende | - |
Actions en circulation | 10,79M |
Volume moyen (1 semaine) | 56,81k |
Volume moyen (1 mois) | 33,51k |
Variation sur 52 semaines | 69,00% |
Plus haut sur 52 semaines | 11,45 |
Plus bas sur 52 semaines | 2,96 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales